NCT05171075 2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Terminated
Anthos Therapeutics, Inc.
Quercis Pharma AG
Poitiers University Hospital
The Catholic University of Korea
M.D. Anderson Cancer Center
Altor BioScience
Shanghai Zhongshan Hospital